Shopping Cart 0
Cart Subtotal
AED 0

Brain Monitoring Market by Technology(Devices and Accessories),and Application(Epilepsy, Dementia, Parkinsons Disease, Huntingtons Disease, Headache Disorders, Stroke, Traumatic Brain Injuries and Sleep Disorders)-Global Opportunity Analysis and Industry Forecast, 2018-2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 19708

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 33012

Details

According to a new report published by Allied Market Research, titled,"Brain Monitoring Market by Product Type, Procedure, and Application: Global Opportunity Analysis and Industry Forecast, 2018-2025,"The global brain monitoring market generated USD 3,850 million in 2017, and is projected to reach USD 6,595 million by 2025, growing at a CAGR of 6.9% from 2018 to 2025. The electroencephalography devices segment accounted for more than one-fifth of the total market share in 2017.

 

Brain monitoring is a neuro-diagnostics device used to monitor and diagnose the brain abnormalities by exploring the structure and function of the brain. These devices are used to monitor neurological disorders such as Alzheimers, Parkinsons, epilepsy, dementia, multiple sclerosis, sleep disorder, brain tumor, and others. Increase in incidence of neurological disorders and rise in awareness of diseases boost the demand for brain monitoring devices all across the world.

 

The global brain monitoring devices market has witnessed an exceptional growth in the past few years. The increase in the geriatric population and rise in prevalence of chronic diseases contribute toward the market growth. In addition, advancements in technology is another factor expected to boost the market growth during the forecast period. However, stringent government regulations and unfavorable reimbursement policies are projected to hamper the market growth during the forecast period. Conversely, untapped markets in the developing countries is expected to offer remunerative opportunities for the market players in the near future.

 

Based on product type, the market is segmented into electroencephalography (EEG) devices, magnetoencephalography (MEG) devices, transcranial Doppler (TCD) devices, intracranial pressure (ICP) monitors, cerebral oximeters, magnetic resonance imaging (MRI) devices, computerized tomography (CT) devices, positron emission tomography (PET) devices, sleep monitoring devices, electromyography (EMG) devices, and accessories. The EEG segment was the major revenue contributor in 2017, and is anticipated to continue this trend during the forecast period, owing to the increase in demand for diagnosis of critical disorders such as epilepsy. In addition, it has further influenced companies to focus on the development of brain monitoring EEG devices.

 

Depending on application, the market is categorized into epilepsy, dementia, Parkinsons disease, Huntington's disease, headache disorders, stroke, traumatic brain injuries, sleep disorders, and other diseases. Patients suffering from Parkinsons disease need regular checkups due to lack of treatment. This increases the demand for brain monitoring devices.

 

North America is expected to remain dominant throughout the forecast period attributable to its well-developed healthcare industry, presence of leading manufacturers in the region, and high adoption rate of brain monitoring devices. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period, due to increase in number of geriatric population and rise in purchasing power of countries in the region.

 

The report provides a comprehensive analysis of the key players operating in the global brain monitoring market, namely, Advanced Brain Monitoring, Inc., CAS Medical Systems, Inc., Compumedics Ltd., General Electric Company (GE Healthcare), Koninklijke Philips N.V. (Philips Healthcare), Medtronic Plc., Natus Medical Incorporated, Neural Analytics, Inc., and Siemens AG.

 

The other players in the value chain include Cadwell Laboratories, Neurosoft Limited, Elekta A.B., InfraSacn, Inc., and BrainScope Company, Inc., and others.

Key Findings of the Brain Monitoring Market:

 

Based on product type, the electromyography devices segment is expected to experience rapid growth in the market, and is projected to grow at a highest CAGR of 8.0% from 2018 to 2025.

Depending on procedure, the invasive segment holds the highest share in 2017, and is anticipated to continue this trend during the forecast period.

By application, the traumatic brain injuries segment was the major revenue contributor in 2017, and is anticipated to continue this trend during the forecast period.

U.S. generated the highest revenue in the global brain monitoring market in 2017, accounting for more than two-fifths of the global market in 2017.

LAMEA is estimated to grow at a CAGR of 8.9% during the forecast period.

 

About Us:

 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

READ MORE

Table Of Content

Scope

Chapter: 1: INTRODUCTION

 

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.4. Research methodology

 

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools & models

 

Chapter: 2: EXECUTIVE SUMMARY

 

2.1. CXO perspective

 

Chapter: 3: MARKET OVERVIEW

 

3.1. Market definition and scope

3.2. Key findings

 

3.2.1. Top investment pockets

 

3.3. Top player positioning, 2017

3.4. Market dynamics

 

3.4.1. Drivers

 

3.4.1.1. Increase in the geriatric population

3.4.1.2. Increase in prevalence of neurological disorders

3.4.1.3. Technological advancements

 

3.4.2. Restraints

 

3.4.2.1. Stringent government regulations

3.4.2.2. Unfavorable reimbursement policies

 

3.4.3. Opportunity

 

3.4.3.1. Untapped markets in developing countries

 

Chapter: 4: BRAIN MONITORING MARKET, BY PRODUCT TYPE

 

4.1. Overview

 

4.1.1. Market size and forecast

 

4.2. Electroencephalography devices (EEG)

 

4.2.1. Key market trends, growth factors, and opportunities

4.2.2. Market size and forecast

4.2.3. Market analysis, by country

 

4.3. Magnetoencephalography devices (MEG)

 

4.3.1. Key market trends, growth factors, and opportunities

4.3.2. Market size and forecast

4.3.3. Market analysis, by country

 

4.4. Transcranial Doppler devices (TCD)

 

4.4.1. Key market trends, growth factors, and opportunities

4.4.2. Market size and forecast

4.4.3. Market analysis, by country

 

4.5. Intracranial pressure monitors (ICP)

 

4.5.1. Key market trends, growth factors, and opportunities

4.5.2. Market size and forecast

4.5.3. Market analysis, by country

 

4.6. Cerebral oximeters

 

4.6.1. Key market trends, growth factors, and opportunities

4.6.2. Market size and forecast

4.6.3. Market analysis, by country

 

4.7. Electromyography devices

 

4.7.1. Key market trends, growth factors, and opportunities

4.7.2. Market size and forecast

4.7.3. Market analysis, by country

 

4.8. Magnetic resonance imaging devices (MRI)

 

4.8.1. Key market trends, growth factors, and opportunities

4.8.2. Market size and forecast

4.8.3. Market analysis, by country

 

4.9. Computerized tomography devices (CT)

 

4.9.1. Key market trends, growth factors, and opportunities

4.9.2. Market size and forecast

4.9.3. Market analysis, by country

 

4.10. Positron emission tomography devices (PET)

 

4.10.1. Key market trends, growth factors, and opportunities

4.10.2. Market size and forecast

4.10.3. Market analysis, by country

 

4.11. Sleep monitoring devices

 

4.11.1. Key market trends, growth factors, and opportunities

4.11.2. Market size and forecast

4.11.3. Market analysis, by country

 

4.12. Accessories

 

4.12.1. Key market trends, growth factors, and opportunities

 

4.12.1.1. Electrodes

4.12.1.2. Sensors

4.12.1.3. Paste & Gels

4.12.1.4. Caps

4.12.1.5. Cables

4.12.1.6. Batteries

4.12.1.7. Others

 

4.12.2. Market size and forecast, by region

4.12.3. Market analysis, by country

 

4.13. Other brain monitoring devices

 

4.13.1. Key market trends, growth factors, and opportunities

4.13.2. Market size and forecast

4.13.3. Market analysis, by country

 

Chapter: 5: BRAIN MONITORING MARKET, BY PROCEDURE

 

5.1. Overview

 

5.1.1. Market size and forecast

 

5.2. Invasive

 

5.2.1. Market size and forecast

5.2.2. Market analysis, by country

 

5.3. Non-invasive

 

5.3.1. Market size and forecast

5.3.2. Market analysis, by country

 

Chapter: 6: BRAIN MONITORING MARKET, BY APPLICATION

 

6.1. Overview

 

6.1.1. Market size and forecast

 

6.2. Epilepsy

 

6.2.1. Market size and forecast

6.2.2. Market analysis, by country

 

6.3. Dementia

 

6.3.1. Market size and forecast

6.3.2. Market analysis, by country

 

6.4. Parkinson's Disease

 

6.4.1. Market size and forecast

6.4.2. Market analysis, by country

 

6.5. Huntington's Disease

 

6.5.1. Market size and forecast

6.5.2. Market analysis, by country

 

6.6. Headache Disorders

 

6.6.1. Market size and forecast

6.6.2. Market analysis, by country

 

6.7. Stroke

 

6.7.1. Market size and forecast

6.7.2. Market analysis, by country

 

6.8. Traumatic Brain Injuries

 

6.8.1. Market size and forecast

6.8.2. Market analysis, by country

 

6.9. Sleep Disorders

 

6.9.1. Market size and forecast

6.9.2. Market analysis, by country

 

6.10. Other Diseases

 

6.10.1. Market size and forecast

6.10.2. Market analysis, by country

 

Chapter: 7: BRAIN MONITORING MARKET, BY REGION

 

7.1. Overview

 

7.1.1. Market size and forecast

 

7.2. North America

 

7.2.1. Key market trends, growth factors, and opportunities

7.2.2. Market size and forecast, by product type

7.2.3. Market size and forecast, by procedure

7.2.4. Market size and forecast, by application

7.2.5. North America market size and forecast, by country

 

7.2.5.1. U.S. market size and forecast, by product type

7.2.5.2. U.S. market size and forecast, by procedure

7.2.5.3. U.S. market size and forecast, by application

7.2.5.4. Canada market size and forecast, by product type

7.2.5.5. Canada market size and forecast, by procedure

7.2.5.6. Canada market size and forecast, by application

7.2.5.7. Mexico market size and forecast, by product type

7.2.5.8. Mexico market size and forecast, by procedure

7.2.5.9. Mexico market size and forecast, by application

 

7.3. Europe

 

7.3.1. Key market trends, growth factors, and opportunities

7.3.2. Market size and forecast, by product type

7.3.3. Market size and forecast, by procedure

7.3.4. Market size and forecast, by application

7.3.5. Europe market size and forecast, by country

 

7.3.5.1. Germany market size and forecast, by product type

7.3.5.2. Germany market size and forecast, by procedure

7.3.5.3. Germany market size and forecast, by application

7.3.5.4. France market size and forecast, by product type

7.3.5.5. France market size and forecast, by procedure

7.3.5.6. France market size and forecast, by application

7.3.5.7. UK market size and forecast, by product type

7.3.5.8. UK market size and forecast, by procedure

7.3.5.9. UK market size and forecast, by application

7.3.5.10. Italy market size and forecast, by product type

7.3.5.11. Italy market size and forecast, by procedure

7.3.5.12. Italy market size and forecast, by application

7.3.5.13. Spain market size and forecast, by product type

7.3.5.14. Spain market size and forecast, by procedure

7.3.5.15. Spain market size and forecast, by application

7.3.5.16. Rest of Europe market size and forecast, by product type

7.3.5.17. Rest of Europe market size and forecast, by procedure

7.3.5.18. Rest of Europe market size and forecast, by application

 

7.4. Asia-Pacific

 

7.4.1. Key market trends, growth factors, and opportunities

7.4.2. Market size and forecast, by product type

7.4.3. Market size and forecast, by procedure

7.4.4. Market size and forecast, by application

7.4.5. Asia-Pacific market size and forecast, by country

 

7.4.5.1. Japan market size and forecast, by product type

7.4.5.2. Japan market size and forecast, by procedure

7.4.5.3. Japan market size and forecast, by application

7.4.5.4. China market size and forecast, by product type

7.4.5.5. China market size and forecast, by procedure

7.4.5.6. China market size and forecast, by application

7.4.5.7. Australia market size and forecast, by product type

7.4.5.8. Australia market size and forecast, by procedure

7.4.5.9. Australia market size and forecast, by application

7.4.5.10. India market size and forecast, by product type

7.4.5.11. India market size and forecast, by procedure

7.4.5.12. India market size and forecast, by application

7.4.5.13. Rest of Asia-Pacific market size and forecast, by product type

7.4.5.14. Rest of Asia-Pacific market size and forecast, by procedure

7.4.5.15. Rest of Asia-Pacific market size and forecast, by application

 

7.5. LAMEA

 

7.5.1. Key market trends, growth factors, and opportunities

7.5.2. Market size and forecast, by product type

7.5.3. Market size and forecast, by procedure

7.5.4. Market size and forecast, by application

7.5.5. LAMEA market size and forecast, by country

 

7.5.5.1. Brazil market size and forecast, by product type

7.5.5.2. Brazil market size and forecast, by procedure

7.5.5.3. Brazil market size and forecast, by application

7.5.5.4. Saudi Arabia market size and forecast, by product type

7.5.5.5. Saudi Arabia market size and forecast, by procedure

7.5.5.6. Saudi Arabia market size and forecast, by application

7.5.5.7. South Africa market size and forecast, by product type

7.5.5.8. South Africa market size and forecast, by procedure

7.5.5.9. South Africa market size and forecast, by application

7.5.5.10. Rest of LAMEA market size and forecast, by product type

7.5.5.11. Rest of LAMEA market size and forecast, by procedure

7.5.5.12. Rest of LAMEA market size and forecast, by application

 

Chapter: 8: COMPANY PROFILES

 

8.1. ADVANCED BRAIN MONITORING, INC.

 

8.1.1. Company overview

8.1.2. Company snapshot

8.1.3. Operating business segments

8.1.4. Product portfolio

 

8.2. CAS MEDICAL SYSTEMS, INC.

 

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Product portfolio

8.2.4. Business performance

 

8.3. COMPUMEDICS LTD.

 

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Operating business segments

8.3.4. Product Portfolio

8.3.5. Business performance

 

8.4. GENERAL ELECTRIC COMPANY (GE HEALTHCARE)

 

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Operating business segments

8.4.4. Product portfolio

8.4.5. Business performance

8.4.6. Key strategic moves and developments

 

8.5. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)

 

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Operating business segments

8.5.4. Product portfolio

8.5.5. Business performance

8.5.6. Key strategic moves and developments

 

8.6. MEDTRONIC PLC.

 

8.6.1. Company overview

8.6.2. Company snapshot

8.6.3. Operating business segments

8.6.4. Product portfolio

8.6.5. Business performance

 

8.7. NATUS MEDICAL INCORPORATED

 

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Product portfolio

8.7.5. Business performance

 

8.8. NEURAL ANALYTICS, INC.

 

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Product portfolio

8.8.4. Key strategic moves and developments

 

8.9. NIHON KOHDEN CORPORATION

 

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Product portfolio

8.9.5. Business performance

8.9.6. Key strategic moves and developments

 

8.10. SIEMENS AG

 

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Operating business segments

8.10.4. Product portfolio

8.10.5. Business performance


List Of Figure

LIST OF FIGURES

 

FIGURE 01. BRAIN MONITORING MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS

FIGURE 03. TOP PLAYER POSITIONING, 2017

FIGURE 04. GLOBAL BRAIN MONITORING MARKET: DRIVERS AND RESTRAINTS

FIGURE 05. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR ELECTROENCEPHALOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 06. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR MAGNETOENCEPHALOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 07. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR TRANSCRANIAL DOPPLER DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 08. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR INTRACRANIAL PRESSURE MONITORS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 09. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR CEREBRAL OXIMETERS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 10. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR ELECTROMYOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR MAGNETIC RESONANCE IMAGING DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR COMPUTERIZED TOMOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR POSITRON EMISSION TOMOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR SLEEP MONITORING DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR ACCESSORIES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR OTHER BRAIN MONITORING DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR INVASIVE, BY COUNTRY, 2017 & 2025 (%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR NON-INVASIVE, BY COUNTRY, 2017 & 2025 (%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR EPILEPSY, BY COUNTRY, 2017 & 2025 (%)

FIGURE 20. PERCENTAGE OF THE TOTAL POPULATION AGED 60 YEARS AND OVER, BY COUNTRY INCOME LEVEL, 2015 TO 2050

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR DEMENTIA, BY COUNTRY, 2017 & 2025 (%)

FIGURE 22. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2017 & 2025 (%)

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR HUNTINGTON'S DISEASE, BY COUNTRY, 2017 & 2025 (%)

FIGURE 24. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 25. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR STROKE, BY COUNTRY, 2017 & 2025 (%)

FIGURE 26. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURIES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 27. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 28. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR OTHER DISEASES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 29. CASMED: REVENUE, 2015-2017 (USD MILLION)

FIGURE 30. CASMED: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)

FIGURE 31. CASMED: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 32. COMPUMEDICS: REVENUE, 2016-2018 (USD MILLION)

FIGURE 33. COMPUMEDICS: REVENUE SHARE BY REGION, 2018 (%)

FIGURE 34. GE: NET SALES, 2015-2017 (USD MILLION)

FIGURE 35. GE: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 36. GE: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 37. PHILIPS: NET SALES, 2015-2017 (USD MILLION)

FIGURE 38. PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 39. PHILIPS: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 40. MEDTRONIC: NET SALES, 2016-2018 (USD MILLION)

FIGURE 41. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 42. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)

FIGURE 43. NATUS: NET SALES, 2015-2017 (USD MILLION)

FIGURE 44. NATUS: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)

FIGURE 45. NATUS: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 46. NIHON KOHDEN: NET SALES, 2016-2018 (USD MILLION)

FIGURE 47. NIHON KOHDEN: REVENUE SHARE BY PRODUCT SEGMENT, 2018 (%)

FIGURE 48. NIHON KOHDEN: REVENUE SHARE BY REGION, 2018 (%)

FIGURE 49. SEIMENS: NET SALES, 2015-2017 (USD MILLION)

FIGURE 50. SEIMENS: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)

FIGURE 51. SEIMENS: REVENUE SHARE BY REGION, 2017 (%)


List Of Table

LIST OF TABLES

 

TABLE 01. GLOBAL BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 02. BRAIN MONITORING MARKET FOR ELECTROENCEPHALOGRAPHY DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 03. BRAIN MONITORING MARKET FOR MAGNETOENCEPHALOGRAPHY DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 04. BRAIN MONITORING MARKET FOR TRANSCRANIAL DOPPLER DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 05. BRAIN MONITORING MARKET FOR INTRACRANIAL PRESSURE MONITORS, BY REGION, 2017-2025 (USD MILLION)

TABLE 06. BRAIN MONITORING MARKET FOR CEREBRAL OXIMETERS, BY REGION, 2017-2025 (USD MILLION)

TABLE 07. BRAIN MONITORING MARKET FOR ELECTROMYOGRAPHY DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 08. BRAIN MONITORING MARKET FOR MAGNETIC RESONANCE IMAGING DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 09. BRAIN MONITORING MARKET FOR COMPUTERIZED TOMOGRAPHY DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 10. BRAIN MONITORING MARKET FOR POSITRON EMISSION TOMOGRAPHY DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 11. BRAIN MONITORING MARKET FOR SLEEP MONITORING DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 12. BRAIN MONITORING MARKET FOR ACCESSORIES, BY REGION, 2017-2025 (USD MILLION)

TABLE 13. BRAIN MONITORING MARKET FOR OTHER BRAIN MONITORING DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 14. GLOBAL BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 15. BRAIN MONITORING MARKET FOR INVASIVE, BY REGION, 2017-2025 (USD MILLION)

TABLE 16. BRAIN MONITORING MARKET FOR NON-INVASIVE, BY REGION, 2017-2025 (USD MILLION)

TABLE 17. GLOBAL BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 18. BRAIN MONITORING MARKET FOR EPILEPSY, BY REGION, 2017-2025 (USD MILLION)

TABLE 19. BRAIN MONITORING MARKET FOR DEMENTIA, BY REGION, 2017-2025 (USD MILLION)

TABLE 20. BRAIN MONITORING MARKET FOR PARKINSON'S DISEASE, BY REGION, 2017-2025 (USD MILLION)

TABLE 21. BRAIN MONITORING MARKET FOR HUNTINGTON'S DISEASE, BY REGION, 2017-2025 (USD MILLION)

TABLE 22. BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY REGION, 2017-2025 (USD MILLION)

TABLE 23. BRAIN MONITORING MARKET FOR STROKE, BY REGION, 2017-2025 (USD MILLION)

TABLE 24. BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURIES, BY REGION, 2017-2025 (USD MILLION)

TABLE 25. BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2017-2025 (USD MILLION)

TABLE 26. BRAIN MONITORING MARKET FOR OTHER DISEASES, BY REGION, 2017-2025 (USD MILLION)

TABLE 27. BRAIN MONITORING MARKET FOR ELECTROENCEPHALOGRAPHY DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 28. NORTH AMERICA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 29. NORTH AMERICA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 30. NORTH AMERICA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 31. NORTH AMERICA BRAIN MONITORING MARKET, BY COUNTRY, 2017-2025 (USD MILLION)

TABLE 32. U.S. BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 33. U.S. BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 34. U.S. BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 35. CANADA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 36. CANADA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 37. CANADA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 38. MEXICO BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 39. MEXICO BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 40. MEXICO BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 41. EUROPE BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 42. EUROPE BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 43. EUROPE BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 44. EUROPE BRAIN MONITORING MARKET, BY COUNTRY, 2017-2025 (USD MILLION)

TABLE 45. GERMANY BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 46. GERMANY BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 47. GERMANY BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 48. FRANCE BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 49. FRANCE BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 50. FRANCE BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 51. UK BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 52. UK BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 53. UK BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 54. ITALY BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 55. ITALY BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 56. ITALY BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 57. SPAIN BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 58. SPAIN BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 59. SPAIN BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 60. REST OF EUROPE BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 61. REST OF EUROPE BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 62. REST OF EUROPE BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 63. ASIA-PACIFIC BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 64. ASIA-PACIFIC BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 65. ASIA-PACIFIC BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 66. ASIA-PACIFIC BRAIN MONITORING MARKET, BY COUNTRY, 2017-2025 (USD MILLION)

TABLE 67. JAPAN BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 68. JAPAN BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 69. JAPAN BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 70. CHINA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 71. CHINA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 72. CHINA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 73. AUSTRALIA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 74. AUSTRALIA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 75. AUSTRALIA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 76. INDIA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 77. INDIA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 78. INDIA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 79. REST OF ASIA-PACIFIC BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 80. REST OF ASIA-PACIFIC BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 81. REST OF ASIA-PACIFIC BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 82. LAMEA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 83. LAMEA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 84. LAMEA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 85. LAMEA BRAIN MONITORING MARKET, BY COUNTRY, 2017-2025 (USD MILLION)

TABLE 86. BRAZIL BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 87. BRAZIL BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 88. BRAZIL BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 89. SAUDI ARABIA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 90. SAUDI ARABIA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 91. SAUDI ARABIA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 92. SOUTH AFRICA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 93. SOUTH AFRICA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 94. SOUTH AFRICA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 95. REST OF LAMEA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 96. REST OF LAMEA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 97. REST OF LAMEA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 98. ADVANCED BRAIN MONITORING: COMPANY SNAPSHOT

TABLE 99. ADVANCED BRAIN MONITORING: BUSINESS AREA

TABLE 100. ADVANCED BRAIN MONITORING: PRODUCT PORTFOLIO

TABLE 101. CASMED: COMPANY SNAPSHOT

TABLE 102. CASMED: PRODUCT PORTFOLIO

TABLE 103. COMPUMEDICS: COMPANY SNAPSHOT

TABLE 104. COMPUMEDICS: PRODUCT PORTFOLIO

TABLE 105. GE: COMPANY SNAPSHOT

TABLE 106. GE: OPERATING SEGMENTS

TABLE 107. GE: PRODUCT PORTFOLIO

TABLE 108. PHILIPS: COMPANY SNAPSHOT

TABLE 109. PHILIPS: OPERATING SEGMENTS

TABLE 110. PHILIPS: PRODUCT PORTFOLIO

TABLE 111. MEDTRONIC: COMPANY SNAPSHOT

TABLE 112. MEDTRONIC: OPERATING SEGMENTS

TABLE 113. MEDTRONIC: PRODUCT PORTFOLIO

TABLE 114. NATUS: COMPANY SNAPSHOT

TABLE 115. NATUS: PRODUCT PORTFOLIO

TABLE 116. NEURAL ANALYTICS: COMPANY SNAPSHOT

TABLE 117. NEURAL ANALYTICS: PRODUCT PORTFOLIO

TABLE 118. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT

TABLE 119. GSK: PRODUCT PORTFOLIO

TABLE 120. SEIMENS: COMPANY SNAPSHOT

TABLE 121. SEIMENS: PRODUCT SEGMENTS

TABLE 122. SEIMENS: PRODUCT PORTFOLIO

Licence Rights

Single-User license:

This  grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

 

Five-User License:

This  grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

 

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

 

Enterprise License:

This  grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

According to a new report published by Allied Market Research, titled,"Brain Monitoring Market by Product Type, Procedure, and Application: Global Opportunity Analysis and Industry Forecast, 2018-2025,"The global brain monitoring market generated USD 3,850 million in 2017, and is projected to reach USD 6,595 million by 2025, growing at a CAGR of 6.9% from 2018 to 2025. The electroencephalography devices segment accounted for more than one-fifth of the total market share in 2017.

 

Brain monitoring is a neuro-diagnostics device used to monitor and diagnose the brain abnormalities by exploring the structure and function of the brain. These devices are used to monitor neurological disorders such as Alzheimers, Parkinsons, epilepsy, dementia, multiple sclerosis, sleep disorder, brain tumor, and others. Increase in incidence of neurological disorders and rise in awareness of diseases boost the demand for brain monitoring devices all across the world.

 

The global brain monitoring devices market has witnessed an exceptional growth in the past few years. The increase in the geriatric population and rise in prevalence of chronic diseases contribute toward the market growth. In addition, advancements in technology is another factor expected to boost the market growth during the forecast period. However, stringent government regulations and unfavorable reimbursement policies are projected to hamper the market growth during the forecast period. Conversely, untapped markets in the developing countries is expected to offer remunerative opportunities for the market players in the near future.

 

Based on product type, the market is segmented into electroencephalography (EEG) devices, magnetoencephalography (MEG) devices, transcranial Doppler (TCD) devices, intracranial pressure (ICP) monitors, cerebral oximeters, magnetic resonance imaging (MRI) devices, computerized tomography (CT) devices, positron emission tomography (PET) devices, sleep monitoring devices, electromyography (EMG) devices, and accessories. The EEG segment was the major revenue contributor in 2017, and is anticipated to continue this trend during the forecast period, owing to the increase in demand for diagnosis of critical disorders such as epilepsy. In addition, it has further influenced companies to focus on the development of brain monitoring EEG devices.

 

Depending on application, the market is categorized into epilepsy, dementia, Parkinsons disease, Huntington's disease, headache disorders, stroke, traumatic brain injuries, sleep disorders, and other diseases. Patients suffering from Parkinsons disease need regular checkups due to lack of treatment. This increases the demand for brain monitoring devices.

 

North America is expected to remain dominant throughout the forecast period attributable to its well-developed healthcare industry, presence of leading manufacturers in the region, and high adoption rate of brain monitoring devices. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period, due to increase in number of geriatric population and rise in purchasing power of countries in the region.

 

The report provides a comprehensive analysis of the key players operating in the global brain monitoring market, namely, Advanced Brain Monitoring, Inc., CAS Medical Systems, Inc., Compumedics Ltd., General Electric Company (GE Healthcare), Koninklijke Philips N.V. (Philips Healthcare), Medtronic Plc., Natus Medical Incorporated, Neural Analytics, Inc., and Siemens AG.

 

The other players in the value chain include Cadwell Laboratories, Neurosoft Limited, Elekta A.B., InfraSacn, Inc., and BrainScope Company, Inc., and others.

Key Findings of the Brain Monitoring Market:

 

Based on product type, the electromyography devices segment is expected to experience rapid growth in the market, and is projected to grow at a highest CAGR of 8.0% from 2018 to 2025.

Depending on procedure, the invasive segment holds the highest share in 2017, and is anticipated to continue this trend during the forecast period.

By application, the traumatic brain injuries segment was the major revenue contributor in 2017, and is anticipated to continue this trend during the forecast period.

U.S. generated the highest revenue in the global brain monitoring market in 2017, accounting for more than two-fifths of the global market in 2017.

LAMEA is estimated to grow at a CAGR of 8.9% during the forecast period.

 

About Us:

 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

READ MORE

Scope

Chapter: 1: INTRODUCTION

 

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.4. Research methodology

 

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools & models

 

Chapter: 2: EXECUTIVE SUMMARY

 

2.1. CXO perspective

 

Chapter: 3: MARKET OVERVIEW

 

3.1. Market definition and scope

3.2. Key findings

 

3.2.1. Top investment pockets

 

3.3. Top player positioning, 2017

3.4. Market dynamics

 

3.4.1. Drivers

 

3.4.1.1. Increase in the geriatric population

3.4.1.2. Increase in prevalence of neurological disorders

3.4.1.3. Technological advancements

 

3.4.2. Restraints

 

3.4.2.1. Stringent government regulations

3.4.2.2. Unfavorable reimbursement policies

 

3.4.3. Opportunity

 

3.4.3.1. Untapped markets in developing countries

 

Chapter: 4: BRAIN MONITORING MARKET, BY PRODUCT TYPE

 

4.1. Overview

 

4.1.1. Market size and forecast

 

4.2. Electroencephalography devices (EEG)

 

4.2.1. Key market trends, growth factors, and opportunities

4.2.2. Market size and forecast

4.2.3. Market analysis, by country

 

4.3. Magnetoencephalography devices (MEG)

 

4.3.1. Key market trends, growth factors, and opportunities

4.3.2. Market size and forecast

4.3.3. Market analysis, by country

 

4.4. Transcranial Doppler devices (TCD)

 

4.4.1. Key market trends, growth factors, and opportunities

4.4.2. Market size and forecast

4.4.3. Market analysis, by country

 

4.5. Intracranial pressure monitors (ICP)

 

4.5.1. Key market trends, growth factors, and opportunities

4.5.2. Market size and forecast

4.5.3. Market analysis, by country

 

4.6. Cerebral oximeters

 

4.6.1. Key market trends, growth factors, and opportunities

4.6.2. Market size and forecast

4.6.3. Market analysis, by country

 

4.7. Electromyography devices

 

4.7.1. Key market trends, growth factors, and opportunities

4.7.2. Market size and forecast

4.7.3. Market analysis, by country

 

4.8. Magnetic resonance imaging devices (MRI)

 

4.8.1. Key market trends, growth factors, and opportunities

4.8.2. Market size and forecast

4.8.3. Market analysis, by country

 

4.9. Computerized tomography devices (CT)

 

4.9.1. Key market trends, growth factors, and opportunities

4.9.2. Market size and forecast

4.9.3. Market analysis, by country

 

4.10. Positron emission tomography devices (PET)

 

4.10.1. Key market trends, growth factors, and opportunities

4.10.2. Market size and forecast

4.10.3. Market analysis, by country

 

4.11. Sleep monitoring devices

 

4.11.1. Key market trends, growth factors, and opportunities

4.11.2. Market size and forecast

4.11.3. Market analysis, by country

 

4.12. Accessories

 

4.12.1. Key market trends, growth factors, and opportunities

 

4.12.1.1. Electrodes

4.12.1.2. Sensors

4.12.1.3. Paste & Gels

4.12.1.4. Caps

4.12.1.5. Cables

4.12.1.6. Batteries

4.12.1.7. Others

 

4.12.2. Market size and forecast, by region

4.12.3. Market analysis, by country

 

4.13. Other brain monitoring devices

 

4.13.1. Key market trends, growth factors, and opportunities

4.13.2. Market size and forecast

4.13.3. Market analysis, by country

 

Chapter: 5: BRAIN MONITORING MARKET, BY PROCEDURE

 

5.1. Overview

 

5.1.1. Market size and forecast

 

5.2. Invasive

 

5.2.1. Market size and forecast

5.2.2. Market analysis, by country

 

5.3. Non-invasive

 

5.3.1. Market size and forecast

5.3.2. Market analysis, by country

 

Chapter: 6: BRAIN MONITORING MARKET, BY APPLICATION

 

6.1. Overview

 

6.1.1. Market size and forecast

 

6.2. Epilepsy

 

6.2.1. Market size and forecast

6.2.2. Market analysis, by country

 

6.3. Dementia

 

6.3.1. Market size and forecast

6.3.2. Market analysis, by country

 

6.4. Parkinson's Disease

 

6.4.1. Market size and forecast

6.4.2. Market analysis, by country

 

6.5. Huntington's Disease

 

6.5.1. Market size and forecast

6.5.2. Market analysis, by country

 

6.6. Headache Disorders

 

6.6.1. Market size and forecast

6.6.2. Market analysis, by country

 

6.7. Stroke

 

6.7.1. Market size and forecast

6.7.2. Market analysis, by country

 

6.8. Traumatic Brain Injuries

 

6.8.1. Market size and forecast

6.8.2. Market analysis, by country

 

6.9. Sleep Disorders

 

6.9.1. Market size and forecast

6.9.2. Market analysis, by country

 

6.10. Other Diseases

 

6.10.1. Market size and forecast

6.10.2. Market analysis, by country

 

Chapter: 7: BRAIN MONITORING MARKET, BY REGION

 

7.1. Overview

 

7.1.1. Market size and forecast

 

7.2. North America

 

7.2.1. Key market trends, growth factors, and opportunities

7.2.2. Market size and forecast, by product type

7.2.3. Market size and forecast, by procedure

7.2.4. Market size and forecast, by application

7.2.5. North America market size and forecast, by country

 

7.2.5.1. U.S. market size and forecast, by product type

7.2.5.2. U.S. market size and forecast, by procedure

7.2.5.3. U.S. market size and forecast, by application

7.2.5.4. Canada market size and forecast, by product type

7.2.5.5. Canada market size and forecast, by procedure

7.2.5.6. Canada market size and forecast, by application

7.2.5.7. Mexico market size and forecast, by product type

7.2.5.8. Mexico market size and forecast, by procedure

7.2.5.9. Mexico market size and forecast, by application

 

7.3. Europe

 

7.3.1. Key market trends, growth factors, and opportunities

7.3.2. Market size and forecast, by product type

7.3.3. Market size and forecast, by procedure

7.3.4. Market size and forecast, by application

7.3.5. Europe market size and forecast, by country

 

7.3.5.1. Germany market size and forecast, by product type

7.3.5.2. Germany market size and forecast, by procedure

7.3.5.3. Germany market size and forecast, by application

7.3.5.4. France market size and forecast, by product type

7.3.5.5. France market size and forecast, by procedure

7.3.5.6. France market size and forecast, by application

7.3.5.7. UK market size and forecast, by product type

7.3.5.8. UK market size and forecast, by procedure

7.3.5.9. UK market size and forecast, by application

7.3.5.10. Italy market size and forecast, by product type

7.3.5.11. Italy market size and forecast, by procedure

7.3.5.12. Italy market size and forecast, by application

7.3.5.13. Spain market size and forecast, by product type

7.3.5.14. Spain market size and forecast, by procedure

7.3.5.15. Spain market size and forecast, by application

7.3.5.16. Rest of Europe market size and forecast, by product type

7.3.5.17. Rest of Europe market size and forecast, by procedure

7.3.5.18. Rest of Europe market size and forecast, by application

 

7.4. Asia-Pacific

 

7.4.1. Key market trends, growth factors, and opportunities

7.4.2. Market size and forecast, by product type

7.4.3. Market size and forecast, by procedure

7.4.4. Market size and forecast, by application

7.4.5. Asia-Pacific market size and forecast, by country

 

7.4.5.1. Japan market size and forecast, by product type

7.4.5.2. Japan market size and forecast, by procedure

7.4.5.3. Japan market size and forecast, by application

7.4.5.4. China market size and forecast, by product type

7.4.5.5. China market size and forecast, by procedure

7.4.5.6. China market size and forecast, by application

7.4.5.7. Australia market size and forecast, by product type

7.4.5.8. Australia market size and forecast, by procedure

7.4.5.9. Australia market size and forecast, by application

7.4.5.10. India market size and forecast, by product type

7.4.5.11. India market size and forecast, by procedure

7.4.5.12. India market size and forecast, by application

7.4.5.13. Rest of Asia-Pacific market size and forecast, by product type

7.4.5.14. Rest of Asia-Pacific market size and forecast, by procedure

7.4.5.15. Rest of Asia-Pacific market size and forecast, by application

 

7.5. LAMEA

 

7.5.1. Key market trends, growth factors, and opportunities

7.5.2. Market size and forecast, by product type

7.5.3. Market size and forecast, by procedure

7.5.4. Market size and forecast, by application

7.5.5. LAMEA market size and forecast, by country

 

7.5.5.1. Brazil market size and forecast, by product type

7.5.5.2. Brazil market size and forecast, by procedure

7.5.5.3. Brazil market size and forecast, by application

7.5.5.4. Saudi Arabia market size and forecast, by product type

7.5.5.5. Saudi Arabia market size and forecast, by procedure

7.5.5.6. Saudi Arabia market size and forecast, by application

7.5.5.7. South Africa market size and forecast, by product type

7.5.5.8. South Africa market size and forecast, by procedure

7.5.5.9. South Africa market size and forecast, by application

7.5.5.10. Rest of LAMEA market size and forecast, by product type

7.5.5.11. Rest of LAMEA market size and forecast, by procedure

7.5.5.12. Rest of LAMEA market size and forecast, by application

 

Chapter: 8: COMPANY PROFILES

 

8.1. ADVANCED BRAIN MONITORING, INC.

 

8.1.1. Company overview

8.1.2. Company snapshot

8.1.3. Operating business segments

8.1.4. Product portfolio

 

8.2. CAS MEDICAL SYSTEMS, INC.

 

8.2.1. Company overview

8.2.2. Company snapshot

8.2.3. Product portfolio

8.2.4. Business performance

 

8.3. COMPUMEDICS LTD.

 

8.3.1. Company overview

8.3.2. Company snapshot

8.3.3. Operating business segments

8.3.4. Product Portfolio

8.3.5. Business performance

 

8.4. GENERAL ELECTRIC COMPANY (GE HEALTHCARE)

 

8.4.1. Company overview

8.4.2. Company snapshot

8.4.3. Operating business segments

8.4.4. Product portfolio

8.4.5. Business performance

8.4.6. Key strategic moves and developments

 

8.5. KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)

 

8.5.1. Company overview

8.5.2. Company snapshot

8.5.3. Operating business segments

8.5.4. Product portfolio

8.5.5. Business performance

8.5.6. Key strategic moves and developments

 

8.6. MEDTRONIC PLC.

 

8.6.1. Company overview

8.6.2. Company snapshot

8.6.3. Operating business segments

8.6.4. Product portfolio

8.6.5. Business performance

 

8.7. NATUS MEDICAL INCORPORATED

 

8.7.1. Company overview

8.7.2. Company snapshot

8.7.3. Operating business segments

8.7.4. Product portfolio

8.7.5. Business performance

 

8.8. NEURAL ANALYTICS, INC.

 

8.8.1. Company overview

8.8.2. Company snapshot

8.8.3. Product portfolio

8.8.4. Key strategic moves and developments

 

8.9. NIHON KOHDEN CORPORATION

 

8.9.1. Company overview

8.9.2. Company snapshot

8.9.3. Operating business segments

8.9.4. Product portfolio

8.9.5. Business performance

8.9.6. Key strategic moves and developments

 

8.10. SIEMENS AG

 

8.10.1. Company overview

8.10.2. Company snapshot

8.10.3. Operating business segments

8.10.4. Product portfolio

8.10.5. Business performance


List Of Figure

LIST OF FIGURES

 

FIGURE 01. BRAIN MONITORING MARKET SEGMENTATION

FIGURE 02. TOP INVESTMENT POCKETS

FIGURE 03. TOP PLAYER POSITIONING, 2017

FIGURE 04. GLOBAL BRAIN MONITORING MARKET: DRIVERS AND RESTRAINTS

FIGURE 05. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR ELECTROENCEPHALOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 06. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR MAGNETOENCEPHALOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 07. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR TRANSCRANIAL DOPPLER DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 08. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR INTRACRANIAL PRESSURE MONITORS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 09. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR CEREBRAL OXIMETERS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 10. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR ELECTROMYOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR MAGNETIC RESONANCE IMAGING DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR COMPUTERIZED TOMOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR POSITRON EMISSION TOMOGRAPHY DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR SLEEP MONITORING DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR ACCESSORIES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR OTHER BRAIN MONITORING DEVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR INVASIVE, BY COUNTRY, 2017 & 2025 (%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR NON-INVASIVE, BY COUNTRY, 2017 & 2025 (%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR EPILEPSY, BY COUNTRY, 2017 & 2025 (%)

FIGURE 20. PERCENTAGE OF THE TOTAL POPULATION AGED 60 YEARS AND OVER, BY COUNTRY INCOME LEVEL, 2015 TO 2050

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR DEMENTIA, BY COUNTRY, 2017 & 2025 (%)

FIGURE 22. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2017 & 2025 (%)

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR HUNTINGTON'S DISEASE, BY COUNTRY, 2017 & 2025 (%)

FIGURE 24. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 25. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR STROKE, BY COUNTRY, 2017 & 2025 (%)

FIGURE 26. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURIES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 27. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 28. COMPARATIVE SHARE ANALYSIS OF BRAIN MONITORING MARKET FOR OTHER DISEASES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 29. CASMED: REVENUE, 2015-2017 (USD MILLION)

FIGURE 30. CASMED: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)

FIGURE 31. CASMED: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 32. COMPUMEDICS: REVENUE, 2016-2018 (USD MILLION)

FIGURE 33. COMPUMEDICS: REVENUE SHARE BY REGION, 2018 (%)

FIGURE 34. GE: NET SALES, 2015-2017 (USD MILLION)

FIGURE 35. GE: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 36. GE: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 37. PHILIPS: NET SALES, 2015-2017 (USD MILLION)

FIGURE 38. PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 39. PHILIPS: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 40. MEDTRONIC: NET SALES, 2016-2018 (USD MILLION)

FIGURE 41. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 42. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)

FIGURE 43. NATUS: NET SALES, 2015-2017 (USD MILLION)

FIGURE 44. NATUS: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)

FIGURE 45. NATUS: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 46. NIHON KOHDEN: NET SALES, 2016-2018 (USD MILLION)

FIGURE 47. NIHON KOHDEN: REVENUE SHARE BY PRODUCT SEGMENT, 2018 (%)

FIGURE 48. NIHON KOHDEN: REVENUE SHARE BY REGION, 2018 (%)

FIGURE 49. SEIMENS: NET SALES, 2015-2017 (USD MILLION)

FIGURE 50. SEIMENS: REVENUE SHARE BY PRODUCT SEGMENT, 2017 (%)

FIGURE 51. SEIMENS: REVENUE SHARE BY REGION, 2017 (%)


List Of Table

LIST OF TABLES

 

TABLE 01. GLOBAL BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 02. BRAIN MONITORING MARKET FOR ELECTROENCEPHALOGRAPHY DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 03. BRAIN MONITORING MARKET FOR MAGNETOENCEPHALOGRAPHY DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 04. BRAIN MONITORING MARKET FOR TRANSCRANIAL DOPPLER DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 05. BRAIN MONITORING MARKET FOR INTRACRANIAL PRESSURE MONITORS, BY REGION, 2017-2025 (USD MILLION)

TABLE 06. BRAIN MONITORING MARKET FOR CEREBRAL OXIMETERS, BY REGION, 2017-2025 (USD MILLION)

TABLE 07. BRAIN MONITORING MARKET FOR ELECTROMYOGRAPHY DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 08. BRAIN MONITORING MARKET FOR MAGNETIC RESONANCE IMAGING DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 09. BRAIN MONITORING MARKET FOR COMPUTERIZED TOMOGRAPHY DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 10. BRAIN MONITORING MARKET FOR POSITRON EMISSION TOMOGRAPHY DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 11. BRAIN MONITORING MARKET FOR SLEEP MONITORING DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 12. BRAIN MONITORING MARKET FOR ACCESSORIES, BY REGION, 2017-2025 (USD MILLION)

TABLE 13. BRAIN MONITORING MARKET FOR OTHER BRAIN MONITORING DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 14. GLOBAL BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 15. BRAIN MONITORING MARKET FOR INVASIVE, BY REGION, 2017-2025 (USD MILLION)

TABLE 16. BRAIN MONITORING MARKET FOR NON-INVASIVE, BY REGION, 2017-2025 (USD MILLION)

TABLE 17. GLOBAL BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 18. BRAIN MONITORING MARKET FOR EPILEPSY, BY REGION, 2017-2025 (USD MILLION)

TABLE 19. BRAIN MONITORING MARKET FOR DEMENTIA, BY REGION, 2017-2025 (USD MILLION)

TABLE 20. BRAIN MONITORING MARKET FOR PARKINSON'S DISEASE, BY REGION, 2017-2025 (USD MILLION)

TABLE 21. BRAIN MONITORING MARKET FOR HUNTINGTON'S DISEASE, BY REGION, 2017-2025 (USD MILLION)

TABLE 22. BRAIN MONITORING MARKET FOR HEADACHE DISORDERS, BY REGION, 2017-2025 (USD MILLION)

TABLE 23. BRAIN MONITORING MARKET FOR STROKE, BY REGION, 2017-2025 (USD MILLION)

TABLE 24. BRAIN MONITORING MARKET FOR TRAUMATIC BRAIN INJURIES, BY REGION, 2017-2025 (USD MILLION)

TABLE 25. BRAIN MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2017-2025 (USD MILLION)

TABLE 26. BRAIN MONITORING MARKET FOR OTHER DISEASES, BY REGION, 2017-2025 (USD MILLION)

TABLE 27. BRAIN MONITORING MARKET FOR ELECTROENCEPHALOGRAPHY DEVICES, BY REGION, 2017-2025 (USD MILLION)

TABLE 28. NORTH AMERICA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 29. NORTH AMERICA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 30. NORTH AMERICA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 31. NORTH AMERICA BRAIN MONITORING MARKET, BY COUNTRY, 2017-2025 (USD MILLION)

TABLE 32. U.S. BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 33. U.S. BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 34. U.S. BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 35. CANADA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 36. CANADA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 37. CANADA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 38. MEXICO BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 39. MEXICO BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 40. MEXICO BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 41. EUROPE BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 42. EUROPE BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 43. EUROPE BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 44. EUROPE BRAIN MONITORING MARKET, BY COUNTRY, 2017-2025 (USD MILLION)

TABLE 45. GERMANY BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 46. GERMANY BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 47. GERMANY BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 48. FRANCE BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 49. FRANCE BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 50. FRANCE BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 51. UK BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 52. UK BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 53. UK BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 54. ITALY BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 55. ITALY BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 56. ITALY BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 57. SPAIN BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 58. SPAIN BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 59. SPAIN BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 60. REST OF EUROPE BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 61. REST OF EUROPE BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 62. REST OF EUROPE BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 63. ASIA-PACIFIC BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 64. ASIA-PACIFIC BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 65. ASIA-PACIFIC BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 66. ASIA-PACIFIC BRAIN MONITORING MARKET, BY COUNTRY, 2017-2025 (USD MILLION)

TABLE 67. JAPAN BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 68. JAPAN BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 69. JAPAN BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 70. CHINA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 71. CHINA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 72. CHINA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 73. AUSTRALIA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 74. AUSTRALIA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 75. AUSTRALIA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 76. INDIA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 77. INDIA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 78. INDIA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 79. REST OF ASIA-PACIFIC BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 80. REST OF ASIA-PACIFIC BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 81. REST OF ASIA-PACIFIC BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 82. LAMEA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 83. LAMEA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 84. LAMEA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 85. LAMEA BRAIN MONITORING MARKET, BY COUNTRY, 2017-2025 (USD MILLION)

TABLE 86. BRAZIL BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 87. BRAZIL BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 88. BRAZIL BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 89. SAUDI ARABIA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 90. SAUDI ARABIA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 91. SAUDI ARABIA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 92. SOUTH AFRICA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 93. SOUTH AFRICA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 94. SOUTH AFRICA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 95. REST OF LAMEA BRAIN MONITORING MARKET, BY PRODUCT TYPE, 2017-2025 (USD MILLION)

TABLE 96. REST OF LAMEA BRAIN MONITORING MARKET, BY PROCEDURE, 2017-2025 (USD MILLION)

TABLE 97. REST OF LAMEA BRAIN MONITORING MARKET, BY APPLICATION, 2017-2025 (USD MILLION)

TABLE 98. ADVANCED BRAIN MONITORING: COMPANY SNAPSHOT

TABLE 99. ADVANCED BRAIN MONITORING: BUSINESS AREA

TABLE 100. ADVANCED BRAIN MONITORING: PRODUCT PORTFOLIO

TABLE 101. CASMED: COMPANY SNAPSHOT

TABLE 102. CASMED: PRODUCT PORTFOLIO

TABLE 103. COMPUMEDICS: COMPANY SNAPSHOT

TABLE 104. COMPUMEDICS: PRODUCT PORTFOLIO

TABLE 105. GE: COMPANY SNAPSHOT

TABLE 106. GE: OPERATING SEGMENTS

TABLE 107. GE: PRODUCT PORTFOLIO

TABLE 108. PHILIPS: COMPANY SNAPSHOT

TABLE 109. PHILIPS: OPERATING SEGMENTS

TABLE 110. PHILIPS: PRODUCT PORTFOLIO

TABLE 111. MEDTRONIC: COMPANY SNAPSHOT

TABLE 112. MEDTRONIC: OPERATING SEGMENTS

TABLE 113. MEDTRONIC: PRODUCT PORTFOLIO

TABLE 114. NATUS: COMPANY SNAPSHOT

TABLE 115. NATUS: PRODUCT PORTFOLIO

TABLE 116. NEURAL ANALYTICS: COMPANY SNAPSHOT

TABLE 117. NEURAL ANALYTICS: PRODUCT PORTFOLIO

TABLE 118. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT

TABLE 119. GSK: PRODUCT PORTFOLIO

TABLE 120. SEIMENS: COMPANY SNAPSHOT

TABLE 121. SEIMENS: PRODUCT SEGMENTS

TABLE 122. SEIMENS: PRODUCT PORTFOLIO

Single-User license:

This  grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

 

Five-User License:

This  grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

 

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

 

Enterprise License:

This  grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS